MedWatch

GN Hearing to utilize pandemic experiences in new product launch

Last time the hearing aid manufacturer launched a product was during the pandemic. The market now is more open, meaning that there are more opportunities for physical launching events, says company CEO Gitte Aabo.

Photo: GN Store Nord / PR

GN Hearing, GN Group’s hearing aid manufacturer, announced the launch of a completely new device to succeed the company’s leading product on Tuesday.

Resound Omnia, as the hearing aid is called, will be on shelves at the end of August. Unlike the last time GN Hearing sent a product to the market around two years ago, Omnia’s predecessor generation Resound One, the pandemic has eased off in certain areas, and fewer restrictions give more opportunities.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

FDA fast-tracks Eli Lilly's obesity candidate

Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.

Jefferies spots weaknesses in GN

One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.

Further reading

Related articles

Latest news

See all jobs